Arthritis Care and Research… Autumn 2025 Press Review – Arthritis Care and Research 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Antony Psarras Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid Arthritis Kawano et al. (10.1002/acr.25481) identified incident HF and categorized…
Arthritis and Rheumatology… Autumn 2025 Press Review – Arthritis & Rheumatology 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Antony Psarras Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib Kuley et al. (10.1002/art.43042) analysed markers of neutrophil activation,…
Press Review… Autumn 2025 Press Review – Arthritis Research & Therapy 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Curtis…
Press Review… Autumn 2025 Press Review – The Lancet Rheumatology 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Clementina López-Medina Baricitinib in early polymyalgia rheumatic (BACHELOR): a randomised, double-blind, placebo-controlled, parallel group trial Saraux A, et al. (10.1016/S2665-9913(24)00270-4) aimed to test whether baricitinib…
Miscellaneous… Autumn 2025 Press Review – Miscellanous 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Victoria Konzett Upadacitinib FDA and EMA-approved for treatment of giant cell arteritis after positive results from the SELECT-GCA study Blockmans et al. (10.1056/NEJMoa2413449) compared Upadacitinib…
Press Review… Autumn 2025 Press Review – Rheumatology (Oxford) 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Jacob J.E. Koopman ‘Am I doing this right?’ Physician perceptions of the global assessment in clinical trials of systemic sclerosis Sabanovic and colleagues (10.1093/rheumatology/keaf377) interviewed…
Press Review… Autumn 2025 Press Review – RMD Open 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Omar Dhrif Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study Bartoletti…
Press Review… Autumn 2025 Press Review – Seminars in Arthritis and Rheumatism 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Jacob J.E. Koopman Current evidence on switching between biologic therapies for Still’s disease: a systematic literature review Dagna and colleagues (10.1016/j.semarthrit.2025.152789) studied publications about the…
EMEUNET… Get to know the EMEUNET Chair Diego Benavent 21 Aug 202528 Aug 2025 Could you tell us about your professional background? I trained in rheumatology in Madrid and now work in Barcelona. I split my time between clinics and research as a rheumatologist…
EMEUNET… EMEUNET activities during EULAR 2025 18 Jul 202518 Jul 2025 Dear EMEUNET Community, Here, we present all EMEUNET activities that took place in Barcelona during EULAR 2025. You will read all the highlights and find out how you can apply…